Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL313676 | 1.00 | MEN1 (0.32) | MEN1NPC1ALDH1A1POLBRAB9A | |
| SCHEMBL4733019 | 0.81 | THRA (0.35) | GSTP1 | |
| SCHEMBL4733020 | 0.81 | THRA (0.35) | GSTP1 | |
| SCHEMBL4734419 | 0.79 | THRA (0.34) | GSTP1 | |
| SCHEMBL4734422 | 0.79 | THRA (0.34) | GSTP1 | |
| SCHEMBL3632525 | 0.75 | — | — | |
| SCHEMBL18043858 | 0.72 | CHRM1 (0.37) | MEN1NPC1ALDH1A1POLBRAB9A | |
| SCHEMBL3401363 | 0.71 | GSTP1 (0.33) | GSTP1 | |
| SCHEMBL3401365 | 0.71 | GSTP1 (0.33) | GSTP1 | |
| SCHEMBL10818144 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2155844-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2012-11-21 | — | — | EP | disclosed |
| US-8278230-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2012-10-02 | — | — | US | disclosed |
| US-8093204-B2 | Organic compounds | GIVAUDAN SA (CH) | 2012-01-10 | — | — | US | disclosed |
| US-20110086793-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2011-04-14 | — | — | US | disclosed |
| EP-2155644-B1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2010-11-17 | — | — | EP | disclosed |
| EP-2155644-B1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2010-11-17 | — | — | EP | disclosed |
| US-20100173821-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2010-07-08 | — | — | US | disclosed |
| US-20100173821-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2010-07-08 | — | — | US | disclosed |
| EP-2155844-A2 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2010-02-24 | — | — | EP | disclosed |
| EP-2155644-A1 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2010-02-24 | — | — | EP | disclosed |
| EP-2155644-A1 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2010-02-24 | — | — | EP | disclosed |
| US-20080305977-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2008-12-11 | — | — | US | disclosed |
| WO-2008148235-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-12-11 | — | — | WO | disclosed |
| WO-2008148235-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-12-11 | — | — | WO | disclosed |
| WO-2008151273-A2 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2008-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086793-A1 | PERFUME SYSTEMS | PAOX, PLIN5, PFKFB2 | MEN1 4590/4885NPC1 2544/4885ALDH1A1 2656/4885 |
| US-20100173821-A1 | Organic Compounds | TRPA1, CYP1B1, TRPV1 | MEN1 2514/4885NPC1 500/4885ALDH1A1 14/4885 |
| US-20080305977-A1 | PERFUME SYSTEMS | PAOX, PLIN5, PFKFB2 | MEN1 4590/4885NPC1 2544/4885ALDH1A1 2656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.